Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Effectiveness study (incl. comparative)
Safety study (incl. comparative)

Data collection methods

Secondary data collection
Non-interventional study

Non-interventional study design

Systematic review and meta-analysis
Study drug and medical condition

Medical condition to be studied

Abortion spontaneous
Postpartum haemorrhage
Stillbirth
Small for dates baby
COVID-19

Additional medical condition(s)

Caesarean delivery, Pregnancy related hypertensive disorders, Preterm birth, Neonatal Intensive Care Unit (NICU) admission, Congenital anomalies, Low birth weight, Neonatal hospitalisation, COVID-19-related hospitalization, COVID-19-related severe illness
Population studied

Short description of the study population

The study focused on effect of covid-19 vaccines on pregnant women and their neonates identified from the Embase and PubMed databases between January 1, 2021, to June 7, 2022.

Age groups

Preterm newborn infants (0 – 27 days)
Infants and toddlers (28 days – 23 months)
Adults (18 to < 46 years)

Special population of interest

Pregnant women

Estimated number of subjects

290000
Study design details

Main study objective

The objective of this scoping literature review was to identify and compile the most recent evidence on the safety and effectiveness of COVID-19 vaccination during pregnancy and breastfeeding.

Outcomes

Pregnancy and delivery outcomes Neonatal outcomes Vaccine effectiveness against SARS-CoV-2 infection COVID-19-related hospitalisation and severe illness

Data analysis plan

A literature search was conducted to include studies published between January 1, 2021, through June 7, 2022. The information sources were EMBASE and PubMed database. The search key terms included: pregnancy, maternal, fetal, birth, perinatal, neonatal, newborn, infant, breastfeeding, lactation AND covid-19 vaccine, covid-19 vaccination, SARS-CoV-2 vaccine. Studies were included if they presented a comparison group (e.g. unvaccinated women) or used background rates, and if they addressed at least one of the following topics: (1) Safety of COVID-19 vaccines during pregnancy with pregnancy, delivery, or neonatal outcomes, or (2) effectiveness of COVID-19 vaccines against SARS-CoV-2 infection, severe COVID-19 illness, or COVID-19-related complications or death, in pregnant women or their infants. Additionally, we included studies looking at the potential protective effect of COVID-19 vaccination during breastfeeding of infants.
Documents
Study results
English (471.89 KB - PDF)View document